Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The complement system components C3b, C4b, C3a, and C5a are key effector molecules of the complement system, a crucial part of the innate immune system. C3b and C4b function as opsonins, tagging pathogens for phagocytosis. C3a and C5a are anaphylatoxins, inducing inflammation and chemotaxis by binding to C3aR and C5aR, respectively.
Varies depending on the specific component. C3b and C4b act as opsonins, tagging pathogens for phagocytosis. C3a and C5a act as anaphylatoxins, inducing inflammation and chemotaxis by binding to their respective G protein-coupled receptors (C3aR and C5aR).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement System Components (C3b, C4b, C3a, C5a) (N/A).